Paravasthu Mukund (CIK 2039078) reported 9 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-05). Recent activity: Buy NVCR (45,112 shares), Sell NVCR (5,377 shares), Sell NVCR (43,246 shares), Sell NVCR (1,555 shares), Sell NVCR (408 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-05 | NovoCure Ltd (NVCR) | Chief Operating Officer | Buy | 45,112 | $0 |
| 2026-03-05 | NovoCure Ltd (NVCR) | Chief Operating Officer | Sell | 5,377 | $71,568 |
| 2026-03-05 | NovoCure Ltd (NVCR) | Chief Operating Officer | Sell | 43,246 | $595,497 |
| 2026-03-03 | NovoCure Ltd (NVCR) | Chief Operating Officer | Sell | 1,555 | $21,241 |
| 2026-03-03 | NovoCure Ltd (NVCR) | Chief Operating Officer | Sell | 408 | $5,504 |
| 2026-01-12 | NovoCure Ltd (NVCR) | Chief Operating Officer | Sell | 2,133 | $30,609 |
| 2025-11-04 | NovoCure Ltd (NVCR) | Chief Operating Officer | Sell | 168 | $2,152 |
| 2025-11-04 | NovoCure Ltd (NVCR) | Chief Operating Officer | Sell | 2,949 | $36,066 |
| 2025-05-05 | NovoCure Ltd (NVCR) | Chief Operating Officer | Sell | 592 | $10,603 |
来源：SEC Form 4 申报文件 · 截至 2026-03-05